Skip to main navigation
Sorry, your browser does not support JavaScript!
Investors
Contact
Global Operations
North America
Canada
Mexico
USA
South America
Argentina
Brazil
Asia
China
Hong Kong
India
Japan
Korea
Singapore
Taiwan
Middle East
United Arab Emirates
Africa
South Africa
Australia
Australia New Zealand
Europe
Austria
Belgium Luxembourg
Czech Republic
Denmark
Finland
France
Germany
Greece
Ireland
Israel
Italy
Netherlands
Norway
Poland
Portugal
Russia
Spain
Sweden
Switzerland
Turkey
United Kingdom
Our Purpose
Mission and Core Values
Partnerships and Community
Advancing Global Health
Giving
Medication Access
About
Leadership
Ethics and Code of Conduct
U.S. Locations
Science & Medicine
Medicines
Pipeline
Research
News and Press
Press Room
Company Statements
Events
Annual Report
Careers
Now Hiring
Culture
Diversity & Inclusion
Benefits
Internships
Utility
Privacy Statements
Terms Of Use
Social Media Guidelines
EU Data Disclosure
Sitemap
BACK TO MAIN MENU
Partnerships and Community
COMPASS Initiative
Gilead Lift
Gilead HIV Age Positively
BACK TO MAIN MENU
Advancing Global Health
HCV Elimination
Ebola
BACK TO MAIN MENU
Giving
Grant Recipients
Grant Funding
Gilead Foundation
Gilead Public Health Award
BACK TO MAIN MENU
Medication Access
U.S. Patient Access
Disaster Product Replacement
Global Access
BACK TO MAIN MENU
Ethics and Code of Conduct
Policies
Global Transparency
Anti-Counterfeiting
Consumer Product Safety
Supplier Info
Authorized Distributors
BACK TO MAIN MENU
Research
Compassionate Use
Investigator Sponsored Research
Clinical Trials
HIV/HCV No Co-Infection (NoCo) 2018 Program
BACK TO MAIN MENU
Press Room
Press Releases
Press FAQS
BACK TO MAIN MENU
Company Statements
Discount For Ambisome
Gilead 2017 Year in Review
100 Corporate Equality Score
Emergency Disaster Response
Gilead Year in Review 2016
Top Corporate Philanthropist
HIV Medicines Reach 10 Million People
Discover Study Of FTAF For PrEP
Corporate Responsibility Report 2015
Gilead Supports PrEP Education
Corporate Contributions Report
Celebrating Transgender Awareness Week
Kite Pharma
Harnessing The Immune System
Grants for SCLAN
Authorized Generics For HCV
BACK TO MAIN MENU
Annual Report
2017 Year in Review
BACK TO MAIN MENU
Privacy Statements
Cookie Statement
Website Privacy Statement
BACK TO MAIN MENU
Social Media Guidelines
Linkedin Guidelines
Twitter Guidelines
BACK TO MAIN MENU
North America
Canada
Mexico
USA
South America
Argentina
Brazil
Asia
China
Hong Kong
India
Japan
Korea
Singapore
Taiwan
Middle East
United Arab Emirates
Africa
South Africa
Australia
Australia New Zealand
Europe
Austria
Belgium Luxembourg
Czech Republic
Denmark
Finland
France
Germany
Greece
Ireland
Israel
Italy
Netherlands
Norway
Poland & The Baltics
Portugal
Russia
Spain
Sweden
Switzerland
Turkey
United Kingdom
BACK TO MAIN MENU
Contact
Request Medication Information
Information for Suppliers
Partnership Request
Investors
Contact
Global Operations
Toggle Inner Dropdown
BACK TO MAIN MENU
Google.com
Investor Calendar
Gilead Sciences 2020 Stockholders Meeting
May 6, 2020 at 10:00 AM PDT
Click here for webcast
Headline
Close
×
Intersititial body copy
